UM
GILD icon

UniSuper Management’s Gilead Sciences GILD Stock Holding History

UniSuper Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.4M Buy
351,688
+43,550
+14% +$5.74M 0.23% 86
2026
Q1 		$42.9M Sell
308,138
-129,596
-30% -$18.1M 0.28% 76
2025
Q4 		$53.7M Sell
437,734
-124,258
-22% -$15.1M 0.32% 67
2025
Q3 		$62.4M Buy
561,992
+15,479
+3% +$1.76M 0.38% 54
2025
Q2 		$60.6M Sell
546,513
-1,454
-0.3% -$155K 0.41% 51
2025
Q1 		$61.4M Buy
547,967
+137,308
+33% +$14.2M 0.46% 38
2024
Q4 		$37.9M Buy
410,659
+181,510
+79% +$16.3M 0.27% 75
2024
Q3 		$19.2M Sell
229,149
-34,124
-13% -$2.6M 0.14% 116
2024
Q2 		$18.1M Buy
263,273
+67,784
+35% +$4.52M 0.15% 108
2024
Q1 		$14.3M Buy
195,489
+19,398
+11% +$1.49M 0.14% 116
2023
Q4 		$14.3M Sell
176,091
-8,952
-5% -$697K 0.16% 110
2023
Q3 		$13.9M Sell
185,043
-52,230
-22% -$4.02M 0.17% 105
2023
Q2 		$18.3M Buy
+237,273
New +$18.9M 0.21% 97

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UniSuper Management's GILD Position: Q2 2026 in Review

UniSuper Management increased its Gilead Sciences (GILD) stake by 14% in Q2 2026, buying an estimated $5.74M and bringing the position to 351,688 shares worth $44.4M. The position accounts for 0.23% of the portfolio, ranked #86.

UniSuper Management first reported a position in GILD in Q2 2023 and has held it in 13 quarters since. The position peaked at $62.4M in Q3 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • UniSuper Management held 351,688 shares of Gilead Sciences worth $44.4M as of Q2 2026.
  • UniSuper Management bought 43,550 Gilead Sciences shares in Q2 2026, an estimated $5.74M.
  • Gilead Sciences made up 0.23% of UniSuper Management's portfolio in Q2 2026, its #86 holding.
  • UniSuper Management first reported a position in Gilead Sciences in Q2 2023 and has held it in 13 quarters since.
  • UniSuper Management's Gilead Sciences position peaked at $62.4M in Q3 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on UniSuper Management's 13F filing for Q2 2026, filed 14 Aug 2026.